0,874  0,004  Lipoxygenase inhibitor
0,855  0,005  TNF expression inhibitor
0,831  0,011  Transcription factor NF kappa B inhibitor
0,815  0,004  Free radical scavenger
0,820  0,009  Caspase 9 stimulant
0,792  0,004  CTGF expression inhibitor
0,785  0,004  NOS2 expression inhibitor
0,766  0,003  Monophenol monooxygenase inhibitor
0,780  0,019  Apoptosis agonist
0,764  0,005  Antioxidant
0,758  0,005  Prostate cancer treatment
0,766  0,020  Antiinflammatory
0,720  0,009  Chemoprotective
0,702  0,005  Antimutagenic
0,705  0,010  Chemopreventive
0,697  0,005  Amyloid beta aggregation inhibitor
0,679  0,008  12-Lipoxygenase inhibitor
0,671  0,005  Antiprotozoal (Leishmania)
0,660  0,003  TRPA1 agonist
0,657  0,010  Antiallergic
0,630  0,006  Ulceration
0,629  0,005  Superoxide dismutase inhibitor
0,628  0,015  Antihypercholesterolemic
0,621  0,012  Antineoplastic (cervical cancer)
0,594  0,002  Vanilloid 1 agonist
0,614  0,022  GST A substrate
0,617  0,032  Antineoplastic (breast cancer)
0,580  0,003  Vanilloid agonist
0,574  0,013  AR expression inhibitor
0,560  0,009  UDP-glucuronosyltransferase substrate
0,573  0,022  Antiprotozoal
0,563  0,015  Proliferative diseases treatment
0,553  0,005  Melanin inhibitor
0,557  0,018  Antipruritic, allergic
0,550  0,013  Nitric oxide antagonist
0,560  0,030  Antileukemic
0,540  0,011  Antiprotozoal (Trypanosoma)
0,532  0,004  GST P1-1 substrate
0,529  0,002  Keratolytic
0,533  0,006  Antiulcerative
0,542  0,016  UGT1A9 substrate
0,527  0,007  UGT2B4 substrate
0,535  0,022  Vasodilator, peripheral
0,521  0,014  Antiamyloidogenic
0,526  0,023  5 Hydroxytryptamine release stimulant
0,516  0,014  Antipyretic
0,532  0,030  CYP2C9 substrate
0,502  0,004  5-Lipoxygenase inhibitor
0,525  0,035  15-Lipoxygenase inhibitor
0,500  0,013  UGT1A6 substrate
0,524  0,041  Antineoplastic (lung cancer)
0,495  0,014  Tumour necrosis factor alpha release inhibitor
0,485  0,004  CYP2B6 inhibitor
0,485  0,005  VCAM1 expression inhibitor
0,497  0,028  CYP2C19 substrate
0,486  0,022  Caspase 3 stimulant
0,463  0,005  Liver fibrosis treatment
0,484  0,029  Antineoplastic (ovarian cancer)
0,479  0,025  Hepatic disorders treatment
0,465  0,019  CYP1A2 inhibitor
0,454  0,011  P-glycoprotein inhibitor
0,446  0,005  DNA polymerase I inhibitor
0,465  0,025  Apoptosis antagonist
0,467  0,031  CYP2D6 substrate
0,470  0,040  Histamine release inhibitor
0,452  0,022  ICAM1 expression inhibitor
0,453  0,029  Radioprotector
0,430  0,008  Lipid peroxidase inhibitor
0,453  0,043  Antineoplastic (colorectal cancer)
0,448  0,048  Immunosuppressant
0,410  0,012  Non-steroidal antiinflammatory agent
0,424  0,029  Sensitization
0,409  0,017  Transcription factor STAT3 inhibitor
0,402  0,012  UGT1A3 substrate
0,394  0,009  DNA methyltransferase I inhibitor
0,394  0,012  UGT2B7 substrate
0,427  0,045  Antineoplastic (colon cancer)
0,388  0,009  Protein kinase stimulant
0,392  0,013  Skin whitener
0,418  0,040  Antifungal
0,386  0,012  DNA methylase inhibitor
0,376  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,406  0,038  Antineoplastic (brain cancer)
0,403  0,036  Antiosteoporotic
0,384  0,019  UGT1A1 substrate
0,372  0,007  Interleukin 1 antagonist
0,400  0,038  NOS3 expression inhibitor
0,395  0,033  Antineoplastic (non-small cell lung cancer)
0,382  0,023  Transcription factor STAT inhibitor
0,370  0,015  Platelet adhesion inhibitor
0,379  0,024  Antihypertriglyceridemic
0,430  0,079  Alzheimer's disease treatment
0,373  0,028  Antineoplastic (liver cancer)
0,376  0,032  Antineoplastic (glioblastoma multiforme)
0,384  0,039  Antineoplastic (glioma)
0,392  0,051  Bone diseases treatment
0,355  0,014  Tubulin antagonist
0,348  0,008  Phospholipase A2 inhibitor
0,369  0,029  Antiparasitic
0,368  0,029  Vasodilator
0,371  0,033  Mutagenic
0,374  0,039  Cytotoxic
0,344  0,017  Tyrosine 3 hydroxylase inhibitor
0,351  0,024  Antineoplastic (sarcoma)
0,349  0,023  Antihelmintic
0,387  0,061  Stroke treatment
0,360  0,037  Cardiovascular analeptic
0,343  0,020  Hepatoprotectant
0,330  0,017  MAO inhibitor
0,318  0,006  LDLR expression enhancer
0,316  0,011  Glutathione S-transferase substrate
0,330  0,027  Septic shock treatment
0,305  0,005  UGT2B10 substrate
0,361  0,067  Antiprotozoal (Plasmodium)
0,307  0,016  UGT2B15 substrate
0,330  0,042  Interleukin antagonist
0,332  0,044  Radiosensitizer
0,328  0,040  Pyruvate kinase inhibitor
0,296  0,010  Cystathionine beta-synthase inhibitor
0,307  0,021  Pneumotoxic
0,374  0,089  Antibacterial
0,292  0,012  Succinate dehydrogenase inhibitor
0,344  0,067  Cholesterol antagonist
0,283  0,008  ATPase inhibitor
0,278  0,005  HIV-1 integrase (3'-Processing) inhibitor
0,290  0,021  Neurotrophic factor enhancer
0,325  0,058  CYP1A2 substrate
0,325  0,060  Aldehyde oxidase inhibitor
0,303  0,038  Sigma receptor agonist
0,268  0,004  Transcription factor AP-1 inhibitor
0,275  0,019  Genotoxic
0,305  0,050  Antineoplastic (renal cancer)
0,320  0,072  Vasodilator, coronary
0,306  0,060  FMO3 substrate
0,307  0,061  Antineoplastic (multiple myeloma)
0,310  0,065  Antineoplastic (pancreatic cancer)
0,260  0,014  SULT1A3 substrate
0,264  0,019  MAO A inhibitor
0,311  0,066  Cardioprotectant
0,252  0,010  Topoisomerase II alpha inhibitor
0,307  0,066  Lipoprotein disorders treatment
0,338  0,098  CYP2C19 inhibitor
0,289  0,051  5 Hydroxytryptamine uptake stimulant
0,276  0,040  Antihypotensive
0,253  0,017  Antifungal enhancer
0,239  0,004  Ornithine decarboxylase inhibitor
0,290  0,055  GST M1-1 substrate
0,284  0,050  Antineoplastic (lymphocytic leukemia)
0,256  0,024  Phospholipase C inhibitor
0,237  0,006  HIV-1 integrase (Overall Integration) inhibitor
0,272  0,041  Abortion inducer
0,287  0,057  Hypoglycemic
0,325  0,097  CYP2C9 inhibitor
0,243  0,016  Gout treatment
0,242  0,018  MAO B inhibitor
0,317  0,092  CYP3A4 substrate
0,252  0,028  Amylase inhibitor
0,305  0,084  FMO1 substrate
0,287  0,068  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,229  0,013  Alcohol dehydrogenase substrate
0,222  0,006  Thioredoxin inhibitor
0,293  0,080  Respiratory analeptic
0,272  0,059  Antineoplastic (lymphoma)
0,296  0,084  Antineoplastic (small cell lung cancer)
0,224  0,014  SULT1A1 substrate
0,215  0,008  Adenylate cyclase stimulant
0,228  0,021  Cholesterol synthesis inhibitor
0,279  0,073  Insulysin inhibitor
0,298  0,093  Calcium channel activator
0,209  0,005  Leukotriene antagonist
0,281  0,078  Antineoplastic (melanoma)
0,232  0,034  Antiacne
0,220  0,023  Aldehyde dehydrogenase inhibitor
0,199  0,002  Glucose-6-phosphate translocase inhibitor
0,237  0,040  Antipruritic, non-allergic
0,208  0,012  Aldehyde dehydrogenase substrate
0,238  0,044  UGT1A4 substrate
0,265  0,072  Teratogen
0,198  0,005  HIV-1 integrase inhibitor
0,233  0,041  Sepsis treatment
0,205  0,013  Carbonic anhydrase XIII inhibitor
0,194  0,003  ATPase (Vacuolar H+) inhibitor
0,222  0,031  VEGF expression inhibitor
0,205  0,015  Retinopathy treatment
0,202  0,013  Uric acid excretion stimulant
0,196  0,009  Electron transport complex I inhibitor
0,195  0,008  Beta tubulin antagonist
0,270  0,084  Hypoxia-inducible factor 1 alpha inhibitor
0,189  0,004  Leukotriene B4 antagonist
0,219  0,035  Interferon gamma antagonist
0,188  0,005  UGT2B11 substrate
0,215  0,032  Bone formation stimulant
0,266  0,084  Antihypoxic
0,244  0,062  Antimitotic
0,202  0,022  Interleukin 4 antagonist
0,186  0,006  TRPA1 antagonist
0,273  0,093  Antineoplastic (osteosarcoma)
0,194  0,014  Carbonic anhydrase VI inhibitor
0,199  0,020  Xanthine oxidase inhibitor
0,197  0,017  Sulfotransferase substrate
0,201  0,023  Toll-Like receptor 2 antagonist
0,250  0,072  Platelet antagonist
0,209  0,036  Antidote
0,266  0,094  Antipsoriatic
0,235  0,065  Antiviral (HIV)
0,312  0,148  Transcription factor inhibitor
0,261  0,099  Analeptic
0,224  0,062  Carcinogenic
0,209  0,048  Thrombolytic
0,250  0,091  Spasmolytic
0,192  0,036  Skin irritative effect
0,188  0,033  Neurotrophic factor
0,191  0,036  M18 aspartyl aminopeptidase inhibitor
0,203  0,050  Eye irritation, high
0,170  0,018  Breast cancer-resistant protein inhibitor
0,302  0,151  Antiarthritic
0,212  0,062  Insulin sensitizer
0,170  0,025  Choleretic
0,150  0,005  Endocannabinoid uptake inhibitor
0,161  0,016  DOPA decarboxylase inhibitor
0,168  0,023  Carbonic anhydrase III inhibitor
0,226  0,081  Embryotoxic
0,188  0,045  Arachidonic acid antagonist
0,152  0,010  Lipase inhibitor
0,187  0,046  Uterine stimulant
0,187  0,047  Cyclooxygenase inhibitor
0,156  0,016  Antifungal (Pneumocystis)
0,179  0,040  Acetylcholinesterase inhibitor
0,162  0,024  UGT2B1 substrate
0,183  0,048  Antineoplastic (squamous cell carcinoma)
0,182  0,048  Neurotensin receptor agonist
0,253  0,123  Antithrombotic
0,183  0,053  Neuropathy treatment
0,139  0,011  Alpha tubulin antagonist
0,179  0,051  NOS3 expression enhancer
0,161  0,034  Growth stimulant
0,156  0,029  Falcipain inhibitor
0,155  0,029  Carbonic anhydrase XV inhibitor
0,153  0,028  Falcipain 2 inhibitor
0,156  0,033  Expectorant
0,127  0,005  Antitreponemal
0,157  0,035  Interleukin 1b antagonist
0,218  0,096  Vascular (periferal) disease treatment
0,176  0,054  Antineoplastic (carcinoma)
0,150  0,029  Mediator release inhibitor
0,208  0,087  Cardiodepressant
0,171  0,051  Antinephritic
0,162  0,043  Antieczematic
0,153  0,035  Gastritis treatment
0,145  0,028  Dementia treatment
0,139  0,022  NAD(P)H dehydrogenase (quinone) inhibitor
0,160  0,045  Topoisomerase II inhibitor
0,152  0,037  Microtubule formation inhibitor
0,129  0,014  Histone deacetylase stimulant
0,129  0,014  Histone deacetylase SIRT1 stimulant
0,140  0,027  Toll-Like receptor 4 antagonist
0,173  0,061  Protein-tyrosine phosphatase inhibitor
0,139  0,027  Vascular dementia treatment
0,129  0,018  Phosphodiesterase 6D inhibitor
0,195  0,084  Platelet aggregation inhibitor
0,210  0,100  Antidiabetic symptomatic
0,145  0,035  Mucolytic
0,159  0,049  Antiseptic
0,151  0,043  Heat shock protein 70 antagonist
0,121  0,013  SULT1A2 substrate
0,178  0,071  Antineoplastic (gastric cancer)
0,144  0,038  Chelator
0,151  0,045  Protein-tyrosine phosphatase 1B inhibitor
0,175  0,069  Antineoplastic (bone cancer)
0,124  0,019  Peroxisome proliferator-activated receptor gamma agonist
0,200  0,096  Antiglaucomic
0,120  0,017  Leukotriene synthesis inhibitor
0,149  0,053  Farnesoid X receptor antagonist
0,174  0,078  Antirickettsial
0,144  0,050  Proteasome inhibitor
0,156  0,063  Thiol protease inhibitor
0,121  0,030  ABCA1 expression enhancer
0,235  0,145  Sodium/bile acid cotransporter inhibitor
0,128  0,038  Beta glucuronidase inhibitor
0,189  0,100  Angiogenesis stimulant
0,138  0,050  Coagulant
0,109  0,022  Thioredoxin reductase inhibitor
0,146  0,059  Cyclooxygenase 1 inhibitor
0,167  0,081  Phobic disorders treatment
0,144  0,059  Cyclooxygenase 2 inhibitor
0,133  0,051  Sphingosine 1-phosphate receptor 4 antagonist
0,156  0,074  Carcinogenic, group 1
0,153  0,074  UGT2B9 substrate
0,172  0,093  Anesthetic general
0,266  0,188  Calcium channel L-type activator
0,163  0,085  Toxic, respiratory center
0,209  0,134  Antiischemic
0,131  0,058  Papain-like protease (SARS coronavirus) inhibitor
0,080  0,009  Vanilloid 2 antagonist
0,115  0,045  Sphingomyelinase inhibitor
0,192  0,122  DNA damaging
0,179  0,110  Hypolipemic
0,121  0,053  Estrogen antagonist
0,088  0,020  Neuraminidase inhibitor
0,108  0,043  Antineoplastic antibiotic
0,088  0,024  Peroxisome proliferator-activated receptor gamma antagonist
0,067  0,002  Calcium-independent phospholipase A2 inhibitor
0,096  0,032  Glutamate decarboxylase inhibitor
0,074  0,011  Leukotriene C antagonist
0,130  0,069  Antihemorrhagic
0,093  0,035  Estrogen-related receptor beta agonist
0,161  0,103  Antiviral (Influenza)
0,091  0,034  Estrogen receptor alpha antagonist
0,168  0,112  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,087  0,032  Carbonic anhydrase VA inhibitor
0,137  0,082  Pregnane X receptor agonist
0,187  0,133  Interleukin agonist
0,106  0,053  Estrogen receptor beta antagonist
0,108  0,055  Butyrylcholinesterase inhibitor
0,066  0,013  Factor III inhibitor
0,136  0,083  Corneal wound healing stimulator
0,085  0,033  Carbonic anhydrase V inhibitor
0,064  0,014  Histone deacetylase 7 inhibitor
0,062  0,015  Histone deacetylase 8 inhibitor
0,055  0,009  Kainate receptor agonist
0,082  0,036  Phenylalanine 4-hydroxylase inhibitor
0,088  0,043  Macrophage migration inhibitory factor inhibitor
0,177  0,133  Peptidyltransferase inhibitor
0,071  0,028  Transcription factor RelA inhibitor
0,119  0,076  Cathepsin H inhibitor
0,052  0,009  Prostaglandin agonist
0,177  0,135  Nitric-oxide synthase stimulant
0,163  0,122  Histone acetyltransferase inhibitor
0,237  0,196  Antiparkinsonian
0,082  0,041  Histidine decarboxylase inhibitor
0,187  0,146  5 Hydroxytryptamine 1E antagonist
0,114  0,074  Beta amyloid protein antagonist
0,131  0,091  Antiprotozoal (Coccidial)
0,055  0,016  Estrogen receptor alpha agonist
0,073  0,034  Antiemphysemic
0,095  0,056  SULT1E1 substrate
0,052  0,015  Histone deacetylase 9 inhibitor
0,092  0,054  Calcium antagonist
0,067  0,030  Heme oxygenase stimulant
0,101  0,063  Bronchodilator
0,188  0,151  Flavin-containing monooxygenase substrate
0,080  0,044  CDC25A inhibitor
0,046  0,010  Catechol O-methyltransferase inhibitor
0,115  0,079  Contraceptive female
0,048  0,012  Leukotriene C4 antagonist
0,094  0,059  Antiviral (Rhinovirus)
0,081  0,045  GABA aminotransferase inhibitor
0,072  0,038  Histone deacetylase inhibitor
0,169  0,135  ErbB-1 antagonist
0,123  0,090  Hair growth stimulant
0,094  0,062  Prolactin inhibitor
0,107  0,076  Photosensitizer
0,061  0,030  Estrogen agonist
0,038  0,007  CYP24 inhibitor
0,254  0,223  5 Hydroxytryptamine release inhibitor
0,135  0,105  Antihelmintic (Nematodes)
0,064  0,035  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,133  0,105  Ca2+-transporting ATPase inhibitor
0,105  0,077  Acetylcholine release stimulant
0,141  0,113  Tumour necrosis factor antagonist
0,113  0,085  Cyclooxygenase 3 inhibitor
0,077  0,049  GABA B receptor agonist
0,067  0,040  Protease 3C (Human rhinovirus) inhibitor
0,061  0,034  Carbonic anhydrase VB inhibitor
0,084  0,059  Myeloperoxidase inhibitor
0,095  0,069  Nitric-oxide synthase inhibitor
0,085  0,061  Granulocyte macrophage colony stimulating factor agonist
0,139  0,115  Sedative
0,042  0,019  Histone deacetylase 5 inhibitor
0,104  0,082  Cell adhesion inhibitor
0,052  0,031  Carbonic anhydrase XIV inhibitor
0,115  0,094  Cocaine dependence treatment
0,120  0,100  Peroxidase inhibitor
0,051  0,031  Peroxisome proliferator-activated receptor alpha agonist
0,062  0,042  Antimycoplasmal
0,043  0,024  Dopamine D5 agonist
0,039  0,019  Histone deacetylase 2 inhibitor
0,030  0,011  Prostaglandin E2 agonist
0,180  0,162  Antiviral (West Nile virus)
0,037  0,019  Histone deacetylase 11 inhibitor
0,037  0,019  Histone deacetylase class IV inhibitor
0,026  0,009  Vitamin D receptor antagonist
0,035  0,018  Histone deacetylase 10 inhibitor
0,027  0,010  Leukotriene B4 receptor 2 antagonist
0,028  0,011  Retinoic acid receptor agonist
0,044  0,028  Estradiol 17 beta-dehydrogenase inhibitor
0,034  0,018  Prostaglandin D2 agonist
0,026  0,011  Prostaglandin F2 alpha agonist
0,084  0,069  Actinic keratosis treatment
0,224  0,209  DNA directed DNA polymerase inhibitor
0,031  0,017  Leukotriene B4 receptor 1 antagonist
0,156  0,143  Cyclic AMP phosphodiesterase inhibitor
0,071  0,059  Phosphodiesterase VI inhibitor
0,032  0,020  Cyclophilin A inhibitor
0,141  0,129  Catenin beta inhibitor
0,046  0,034  Protease activated receptor 1 antagonist
0,127  0,116  Mcl-1 antagonist
0,107  0,097  Antihyperlipoproteinemic
0,059  0,048  Protease activated receptor antagonist
0,070  0,060  Na+ K+ transporting ATPase inhibitor
0,032  0,022  Squalene synthetase inhibitor
0,037  0,028  Vesicle monoamine transporter inhibitor
0,176  0,168  Neuropeptide Y2 antagonist
0,066  0,057  SULT2A1 substrate
0,089  0,081  Anabolic
0,054  0,047  Prostaglandin EP2 antagonist
0,022  0,015  Retinoic acid gamma receptor agonist
0,045  0,039  Plasminogen activator inhibitor antagonist
0,118  0,111  Cholinergic
0,064  0,059  Anticholelithogenic
0,064  0,060  Catalase inhibitor
0,046  0,042  Prolyl endopeptidase inhibitor
0,051  0,047  Thromboxane synthase inhibitor
0,188  0,184  Angiogenesis inhibitor
0,016  0,013  Vitamin D receptor agonist
0,036  0,033  Retinoic acid alpha receptor agonist
0,028  0,025  Histone deacetylase class IIa inhibitor
0,031  0,029  Retinoid X receptor agonist
0,012  0,009  Calcium-dependent phospholipase A2 inhibitor
0,032  0,030  HMG CoA reductase inhibitor
0,064  0,063  Antibiotic
0,086  0,085  Bile acid receptor antagonist
0,028  0,028  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,048  0,048  Postmenopausal disorders treatment

